Celon Pharma at the BIO International Convention 2019

The Company's representatives will participate in the BIO International Convention 2019, an international convention which attracts over 16.000 biotechnology and pharmacy leaders each year. The conference allows for networking and collaboration in the field of drug development.

Maciej Wieczorek, CEO of Celon Pharma S.A.: We can confirm the growing interest in our projects in the field of neuropsychiatry, especially esketamine, but also in the drugs we are developing to treat metabolic and inflammatory diseases. In June 2019 we will be active participants of the BIO International Convention, where we will hold a number of important meetings with potential partners.